Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7400 p559
13 May 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Query inappropriate requests for ephedrine

Sipa Press/Rex Features

Metamfetamine use

Metamfetamine use could become common in the UK

Pharmacists should question customers who request inappropriate quantities of over-the-counter products containing ephedrine and pseudoephedrine, the Royal Pharmaceutical Society said this week.

The advice follows a warning by the US Drug Enforcement Agency that bulk sales of certain cold remedies should be monitored because of the risk that they may be used to manufacture metamfetamine. Use of this drug (whose street names include crystal meth, crystal, burn, pure, p, crank and meth) is already widespread in the US and the United Nations has advised that it could become common in the UK.

The Society says that metamfetamine can be synthesised relatively easily by reducing ephedrine or pseudoephedrine and is a powerful central nervous system stimulant. Its stimulant effects can last for up to 12 hours after inhalation or oral administration. It can also be administered by smoking or injection.

The Society warns that one of the risks from metamfetamine use is from the increased chance of HIV infection through unprotected sex while under the influence of the product.

Back to Top


©The Pharmaceutical Journal